Study on cases of precocious puberty

Two boys and one girl with idiopathic precocious puberty were treated with medroxyprogesterone acetate (MPA) for 2 years and 2 months to 9 years and 5 months, and its efficiency was evaluated. Treatment with MPA suppressed the gonadotropin levels, the signs and symptoms of patients with precocious p...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 35(1989), 10 vom: 30. Okt., Seite 1715-20
1. Verfasser: Nanbu, A (VerfasserIn)
Weitere Verfasser: Kumamoto, Y, Takagi, Y, Maruta, H
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1989
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Case Reports English Abstract Journal Article Testosterone 3XMK78S47O Luteinizing Hormone 9002-67-9 Follicle Stimulating Hormone 9002-68-0 Medroxyprogesterone Acetate mehr... C2QI4IOI2G Medroxyprogesterone HSU1C9YRES
LEADER 01000naa a22002652 4500
001 NLM025142526
003 DE-627
005 20231221094840.0
007 tu
008 231221s1989 xx ||||| 00| ||jpn c
028 5 2 |a pubmed24n0084.xml 
035 |a (DE-627)NLM025142526 
035 |a (NLM)2532862 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a jpn 
100 1 |a Nanbu, A  |e verfasserin  |4 aut 
245 1 0 |a Study on cases of precocious puberty 
264 1 |c 1989 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 16.02.1990 
500 |a Date Revised 21.11.2013 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Two boys and one girl with idiopathic precocious puberty were treated with medroxyprogesterone acetate (MPA) for 2 years and 2 months to 9 years and 5 months, and its efficiency was evaluated. Treatment with MPA suppressed the gonadotropin levels, the signs and symptoms of patients with precocious puberty, and also had a suppressive effect on bone-age advance, so these patients showed almost normal growth in height. There has been controversy about the age when treatment for idiopathic precocious puberty should be finished. Our data suggested that the treatment should be stopped at 11-13 years when patients reach the age of puberty 
650 4 |a Case Reports 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 7 |a Testosterone  |2 NLM 
650 7 |a 3XMK78S47O  |2 NLM 
650 7 |a Luteinizing Hormone  |2 NLM 
650 7 |a 9002-67-9  |2 NLM 
650 7 |a Follicle Stimulating Hormone  |2 NLM 
650 7 |a 9002-68-0  |2 NLM 
650 7 |a Medroxyprogesterone Acetate  |2 NLM 
650 7 |a C2QI4IOI2G  |2 NLM 
650 7 |a Medroxyprogesterone  |2 NLM 
650 7 |a HSU1C9YRES  |2 NLM 
700 1 |a Kumamoto, Y  |e verfasserin  |4 aut 
700 1 |a Takagi, Y  |e verfasserin  |4 aut 
700 1 |a Maruta, H  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Hinyokika kiyo. Acta urologica Japonica  |d 1962  |g 35(1989), 10 vom: 30. Okt., Seite 1715-20  |w (DE-627)NLM012631779  |x 0018-1994  |7 nnns 
773 1 8 |g volume:35  |g year:1989  |g number:10  |g day:30  |g month:10  |g pages:1715-20 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_40 
912 |a GBV_ILN_60 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_350 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2012 
912 |a GBV_ILN_2018 
951 |a AR 
952 |d 35  |j 1989  |e 10  |b 30  |c 10  |h 1715-20